Notice Number: NOT-CA-20-007
Release Date: November 08, 2019
National Cancer Institute (NCI)
The purpose of this Notice is to extend the expiration date for PAR-18-767 , “Comprehensive Partnerships to Advance Cancer Health Equity (CPACHE) (Collaborative U54 Clinical Trial Optional)," for 1 year and to specify that revision applications will not be accepted and/or considered.
In Part 1, under Key Dates, each of the specified date types now have one additional or new date.
Application Due Date(s)
January 9, 2019; January 9, 2020; January 11, 2021, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Scientific Merit Review
May/June 2019; May/June 2020; May/June 2021
Advisory Council Review
August 2019, August 2020, August 2021
Earliest Start Date
July 2019, September 2020, September 2021
January 12, 2021
In Part 2, under Section II. Award Information, "Revision" is deleted because revision applications are not to be submitted, received, and/or considered. Only Renewal, and Resubmission applications can be submitted, received, and considered. Therefore, the relevant portion of Section II in PAR-18-767 now reads as follows:
Application Types Allowed
The OER Glossary and the SF424 (R&R) Application Guide provide details on these application types.
All other aspects of this FOA remain unchanged.
Please direct all inquiries to:
H. Nelson Aguila, D.V.M.
National Cancer Institute